Carl Zeiss Meditec AG
XETRA:AFX

Watchlist Manager
Carl Zeiss Meditec AG Logo
Carl Zeiss Meditec AG
XETRA:AFX
Watchlist
Price: 46.38 EUR 1.27% Market Closed
Market Cap: 4.1B EUR
Have any thoughts about
Carl Zeiss Meditec AG?
Write Note

Carl Zeiss Meditec AG
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Carl Zeiss Meditec AG
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Carl Zeiss Meditec AG
XETRA:AFX
Revenue
€2.1B
CAGR 3-Years
4%
CAGR 5-Years
4%
CAGR 10-Years
8%
Stratec SE
XETRA:SBS
Revenue
€250.5m
CAGR 3-Years
-5%
CAGR 5-Years
3%
CAGR 10-Years
6%
Eckert & Ziegler Strahlen und Medizintechnik AG
XETRA:EUZ
Revenue
€423.1m
CAGR 3-Years
33%
CAGR 5-Years
19%
CAGR 10-Years
13%
Siemens Healthineers AG
XETRA:SHL
Revenue
€22.1B
CAGR 3-Years
10%
CAGR 5-Years
9%
CAGR 10-Years
N/A
Draegerwerk AG & Co KGaA
XETRA:DRW8
Revenue
€3.3B
CAGR 3-Years
-2%
CAGR 5-Years
4%
CAGR 10-Years
3%
Sartorius AG
XETRA:SRT
Revenue
€3.3B
CAGR 3-Years
1%
CAGR 5-Years
13%
CAGR 10-Years
16%
No Stocks Found

Carl Zeiss Meditec AG
Glance View

Market Cap
4.1B EUR
Industry
Health Care
Economic Moat
None

Carl Zeiss Meditec AG stands as a beacon in the realm of medical technology, carving a niche through its innovative solutions in ophthalmology and microsurgery. Rooted in the prestigious legacy of the Zeiss Group, this company seamlessly fuses cutting-edge technology with practical medical applications. Its headquarters in Jena, Germany, serve as the crucible for pioneering research and development endeavors, channeling expertise into products that enhance both diagnostic and surgical capabilities. The heart of its operations revolves around creating technological marvels such as optical coherence tomography (OCT) instruments and surgical microscopes, which bring precision and enhanced clarity to the medical field. Through a well-executed blend of R&D and strategic acquisitions, Carl Zeiss Meditec consistently remains at the forefront of medical innovation, ensuring it meets the ever-evolving needs of the healthcare sector. Financially, the company thrives by selling its sophisticated medical devices directly to healthcare professionals, hospitals, and clinics worldwide. Rather than merely creating instruments, Carl Zeiss Meditec's business model is deeply entwined with providing comprehensive workflow solutions and service support, ensuring that medical practitioners extract maximum utility from their investments. By offering not just products but also extensive after-sales service and maintenance, the company builds sustained relationships with its clients, fostering a cycle of trust and repeat business. In addition, its engagement in training and support services enhances user competencies, ensuring the seamless integration of its technology into everyday medical practice and underscoring its commitment to elevating healthcare standards globally. Through this multifaceted approach, Carl Zeiss Meditec solidifies its position as an indispensable ally in the medical community, both as a supplier of state-of-the-art equipment and as a provider of essential healthcare solutions.

AFX Intrinsic Value
91.75 EUR
Undervaluation 49%
Intrinsic Value
Price

See Also

What is Carl Zeiss Meditec AG's Revenue?
Revenue
2.1B EUR

Based on the financial report for Jun 30, 2024, Carl Zeiss Meditec AG's Revenue amounts to 2.1B EUR.

What is Carl Zeiss Meditec AG's Revenue growth rate?
Revenue CAGR 10Y
8%

Over the last year, the Revenue growth was -1%. The average annual Revenue growth rates for Carl Zeiss Meditec AG have been 4% over the past three years , 4% over the past five years , and 8% over the past ten years .

Back to Top